Cargando…
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
The antibody-mediated targeted delivery of cytokines to sites of disease is a promising avenue for cancer therapy, but it is largely unexplored for the treatment of chronic inflammatory conditions. Using both radioactive and fluorescent techniques, the human monoclonal antibodies L19 and G11 (specif...
Autores principales: | Trachsel, Eveline, Bootz, Frank, Silacci, Michela, Kaspar, Manuela, Kosmehl, Hartwig, Neri, Dario |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860067/ https://www.ncbi.nlm.nih.gov/pubmed/17261171 http://dx.doi.org/10.1186/ar2115 |
Ejemplares similares
-
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
por: Schwager, Kathrin, et al.
Publicado: (2009) -
Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse
por: Doll, Fabia, et al.
Publicado: (2013) -
Collagen-induced arthritis is exacerbated in IL-10-deficient mice
por: Finnegan, Alison, et al.
Publicado: (2003) -
AAV mediated delivery of IL-4 prevents collagen-induced arthritis
por: Bessis, N, et al.
Publicado: (2001) -
Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4
por: Tarner, IH, et al.
Publicado: (2001)